THC Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
THC Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • THC Therapeutics, Inc. Operating Income (Loss) for the quarter ending April 30, 2024 was -$380K, a 554% decline year-over-year.
  • THC Therapeutics, Inc. Operating Income (Loss) for the twelve months ending April 30, 2024 was -$575K, a 40.9% increase year-over-year.
  • THC Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$494K, a 71.7% increase from 2022.
  • THC Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$1.75M, a 85.8% decline from 2021.
  • THC Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$940K, a 32.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.